Most Recent
Myer class action funder must pay $1M in security for trial
The litigation funder underwriting a class action against Myer will have to fork over another $950,000 in security ahead of what will be a rare shareholder trial starting next Wednesday, a court has ruled.
ACCC is not GSK’s compliance department, court told
The first day of a liability hearing in a consumer case over GlaxoSmithKline's marketing for its popular Voltaren products has seen an ACCC witness deflect accusations the regulator was vague about its misleading packaging concerns, placing the blame squarely on the pharmaceutical giant.
Letters to Kmart bigwigs didn’t breach copyright law, streetwear co. says
Globe International denies that it violated the law when it sent multiple letters to Kmart allegedly threatening legal action for infringing its copyright for cargo pants and shorts.
Debt collector ACM harassed stroke victim, court finds
One of Australia's largest debt collectors, ACM Group, harassed and coerced vulnerable customers -- including a stroke victim -- by bombarding them with phone calls and making empty threats of litigation, the Federal Court found Monday.
Provident Capital class actions settle on eve of trial
A settlement has been reached in two class actions brought on behalf of holders of debentures who allege they suffered losses due to Australian Executor Trustees' mismanagement of debenture issuer Provident Capital.
No holds barred in GetSwift class action challenge
The naming of Squire Patton Boggs as a concurrent wrongdoer in GetSwift’s defence puts the law firm in an “impossible position of conflict of interest” if it wins a challenge to an order staying its class action against the company, the Full Federal Court has been told ahead of a highly anticipated appeal hearing that promises to pull no punches.
ASIC loses bid for interim receiver against AGM, OT, Ozifin
A judge has denied ASIC's bid to appoint an interim receiver to preserve the assets of three financial services companies that advised clients to invest in complex derivatives, which ASIC is seeking to have wound up for alleged violations of the Corporations Act.
Privilege not waived by DLA Piper phone call over Circadin patent
Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals' patents covering sleep drug Circadin, with a court ruling legal professional privilege was waived in a phone conversation between a DLA Piper lawyer and the company's founder.
Rival poppy producers face off again over codeine patents
Two rival poppy processors are facing off in another courtroom battle over patents for high codeine-yielding poppy plants.
Cash Converters ordered to produce data on individuals that took out payday loans
Cash Converters has been ordered to turn over information on people it provided payday loans to in Queensland in a class action alleging it charged a brokerage fee to borrowers for services they never received.